dc.creator | Thakur, Sidharath Dev | |
dc.creator | Araya, Pamela | |
dc.creator | Borthagaray, Graciela | |
dc.creator | Galarza, Patricia G. | |
dc.creator | Hernandez, Alina Llop | |
dc.creator | Payares, Daisy | |
dc.creator | Sanabria Cruz, Olga Marina | |
dc.creator | Carvallo, Maria Elena Trigoso | |
dc.creator | Corredor, Aura Helena | |
dc.creator | Dillon, Jo-Anne R | |
dc.date | 2021-01-20T13:06:59Z | |
dc.date | 2021-01-20T13:06:59Z | |
dc.date | 2017 | |
dc.date.accessioned | 2023-08-29T20:08:58Z | |
dc.date.available | 2023-08-29T20:08:58Z | |
dc.identifier | 1537-4521 | |
dc.identifier | https://europepmc.org/article/med/28178114 | |
dc.identifier | http://sgc.anlis.gob.ar/handle/123456789/2190 | |
dc.identifier | 10.1097/OLQ.0000000000000587 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8520432 | |
dc.description | Fil: Thakur, Sidharath Dev. Department of Microbiology, College of Medicine; Estados Unidos. | |
dc.description | Fil: Araya, Pamela. Instituto de Salud Publica de Chile, Santiago; Chile. | |
dc.description | Fil: Borthagaray, Graciela. Faculdad de Quimica, Universidad de la Republica, Montevideo; Uruguay. | |
dc.description | Fil: Galarza, Patricia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina. | |
dc.description | Fil: Hernandez, Alina Llop. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Medicina Tropical; Argentina. | |
dc.description | Fil: Payares, Daisy. Instituto Nacional Higiene "Rafael Rangel", Caracas; Venezuela. | |
dc.description | Fil: Sanabria Cruz, Olga Marina. Instituto National de Salud, Bogota; Colombia. | |
dc.description | Fil: Carvallo, Maria Elena Trigoso. Centro Departmental de Vigilancia Information y Referencia, CDVIR La Paz; Bolivia. | |
dc.description | Fil: Corredor, Aura Helena. Vaccine and infectious Disease Organization-International Vaccine Center, University of Saskatchewan, Saskatchewan; Canada. | |
dc.description | Fil: Dillon, Jo-Anne R. Vaccine and infectious Disease Organization-International Vaccine Center, University of Saskatchewan, Saskatchewan; Canada. | |
dc.description | Seven countries in Latin America and the Caribbean report on (2010 and 2011) the susceptibility of 2235 isolates of Neisseria gonorrhoeae to 6 antibiotics. Thirteen isolates had ceftriaxone minimum inhibitory concentrations (MICs) of 0.125 to ≥ 0.25 mg/L. The percentage of resistant isolates to the following antibiotics was: azithromycin, 1.0% to 1.7%; ciprofloxacin, 42.1% to 36.2%; penicillin, 31% to 35%; tetracycline, 21.8% to 22.6%. | |
dc.format | pdf | |
dc.language | en | |
dc.publisher | Lippincott, Williams & Wilkins | |
dc.relation | Sexually transmitted diseases | |
dc.rights | open | |
dc.source | Sexually Transmitted Diseases 2017; 44(3):157-160. | |
dc.subject | Neisseria gonorrhoeae | |
dc.subject | Neisseria | |
dc.title | Resistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010-2011 | |
dc.type | Artículo | |